Lougheed W D, Albisser A M, Martindale H M, Chow J C, Clement J R
Diabetes. 1983 May;32(5):424-32. doi: 10.2337/diab.32.5.424.
Insulin aggregation remains a fundamental obstacle to the long-term application of many insulin infusion systems. We here report the effects of physiologic and nonphysiologic compounds on the aggregation behavior of crystalline zinc insulin (CZI) solutions. Under conditions chosen to simulate the most severe that would be encountered in delivery systems (presence of air, continuous motion, and elevated temperature), both highly purified and regular CZI at 5 U/ml formed turbid gels in 5 days. At concentrations of 100 and 500 U/ml stability was increased with turbid gels forming at 12 and 15 days, respectively. Under identical conditions, 5 U/ml CZI formulations containing the physiologic surfactant lysophosphatidylcholine (0.02%) or the synthetic surfactants SDS (1%), Brij 35 (0.1%), Tween (0.01%), or Triton X (0.01%) retained a transmittance at 540 nm of greater than 96% for 67-150 days. These nonionic and ionic surfactants containing the hydrophobic group, CH3(CH2)N, with N = 7-16, remarkably stabilized CZI formulations while those lacking such groups demonstrated little or no effect. The alcohols glycerol (30-50%) and isopropanol (10-50%) were moderately effective stabilizers. Silicone rubber drastically accelerated aggregation in all but one formulation (1% SDS). Emphasis in this study was placed on the properties of 5-U/ml formulations. Controls run at higher concentrations indicated a positive correlation between concentration and stability. It was concluded that the aggregation of insulin into high-molecular-weight polymers may be inhibited by reducing the effective polarity of the solvent. In this regard, anionic and nonionic surfactants containing appropriately long hydrophobic groups demonstrated the greatest degree of stabilization. Finally, of all the medical grade materials likely to be used in pumps, silicone rubber is the most active in promoting insulin aggregation.
胰岛素聚集仍然是许多胰岛素输注系统长期应用的一个基本障碍。我们在此报告生理和非生理化合物对结晶锌胰岛素(CZI)溶液聚集行为的影响。在选择模拟输送系统中最恶劣条件(存在空气、持续运动和温度升高)的情况下,5 U/ml的高纯度和常规CZI在5天内形成浑浊凝胶。在100和500 U/ml的浓度下,稳定性增加,分别在12天和15天形成浑浊凝胶。在相同条件下,含有生理表面活性剂溶血磷脂酰胆碱(0.02%)或合成表面活性剂十二烷基硫酸钠(SDS,1%)、Brij 35(0.1%)、吐温(0.01%)或曲拉通X(0.01%)的5 U/ml CZI制剂在540 nm处的透光率在67至150天内保持大于96%。这些含有疏水基团CH3(CH2)N(N = 7 - 16)的非离子和离子表面活性剂显著稳定了CZI制剂,而缺乏此类基团的表面活性剂则几乎没有效果或没有效果。醇类甘油(30 - 50%)和异丙醇(10 - 50%)是中等有效的稳定剂。除一种制剂(1% SDS)外,硅橡胶在所有制剂中都极大地加速了聚集。本研究重点关注5 U/ml制剂的性质。在更高浓度下进行的对照表明浓度与稳定性之间呈正相关关系。得出的结论是,通过降低溶剂的有效极性可以抑制胰岛素聚集成高分子量聚合物。在这方面,含有适当长疏水基团的阴离子和非离子表面活性剂表现出最大程度的稳定性。最后,在所有可能用于泵的医用级材料中,硅橡胶在促进胰岛素聚集方面最为活跃。